Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

NASDAQ:XMTR - Nasdaq - US98423F1093 - Common Stock - Currency: USD

32.785  +1.72 (+5.55%)

Fundamental Rating

3

Overall XMTR gets a fundamental rating of 3 out of 10. We evaluated XMTR against 47 industry peers in the Trading Companies & Distributors industry. XMTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XMTR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XMTR was profitable.
In the past year XMTR has reported a negative cash flow from operations.
XMTR had negative earnings in each of the past 5 years.
XMTR had a negative operating cash flow in each of the past 5 years.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

XMTR has a worse Return On Assets (-7.08%) than 93.62% of its industry peers.
XMTR has a worse Return On Equity (-15.77%) than 89.36% of its industry peers.
Industry RankSector Rank
ROA -7.08%
ROE -15.77%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

XMTR has a better Gross Margin (39.05%) than 68.09% of its industry peers.
XMTR's Gross Margin has improved in the last couple of years.
XMTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XMTR has been increased compared to 1 year ago.
XMTR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, XMTR has a worse debt to assets ratio.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.70 indicates that XMTR is not a great score, but indicates only limited risk for bankruptcy at the moment.
XMTR has a Altman-Z score (2.70) which is in line with its industry peers.
A Debt/Equity ratio of 0.92 indicates that XMTR is somewhat dependend on debt financing.
XMTR has a Debt to Equity ratio (0.92) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 2.7
ROIC/WACCN/A
WACC9.43%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

XMTR has a Current Ratio of 3.74. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
XMTR's Current ratio of 3.74 is amongst the best of the industry. XMTR outperforms 82.98% of its industry peers.
XMTR has a Quick Ratio of 3.70. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of XMTR (3.70) is better than 97.87% of its industry peers.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.7
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 128.13% over the past year.
XMTR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.36%.
Measured over the past years, XMTR shows a very strong growth in Revenue. The Revenue has been growing by 46.73% on average per year.
EPS 1Y (TTM)128.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)19.36%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%23.05%

3.2 Future

Based on estimates for the next years, XMTR will show a very strong growth in Earnings Per Share. The EPS will grow by 189.04% on average per year.
Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 17.49% on average per year.
EPS Next Y675.28%
EPS Next 2Y291.65%
EPS Next 3Y189.04%
EPS Next 5YN/A
Revenue Next Year19.64%
Revenue Next 2Y18.59%
Revenue Next 3Y17.67%
Revenue Next 5Y17.49%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

XMTR is valuated quite expensively with a Price/Earnings ratio of 364.28.
Based on the Price/Earnings ratio, XMTR is valued a bit more expensive than the industry average as 74.47% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.32. XMTR is valued rather expensively when compared to this.
XMTR is valuated quite expensively with a Price/Forward Earnings ratio of 49.16.
Based on the Price/Forward Earnings ratio, XMTR is valued a bit more expensive than 72.34% of the companies in the same industry.
XMTR is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 364.28
Fwd PE 49.16
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

XMTR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XMTR's earnings are expected to grow with 189.04% in the coming years.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y291.65%
EPS Next 3Y189.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XMTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (6/18/2025, 12:32:24 PM)

32.785

+1.72 (+5.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-08 2025-08-08/bmo
Inst Owners93.25%
Inst Owner Change2.06%
Ins Owners5.8%
Ins Owner Change12.01%
Market Cap1.66B
Analysts80
Price Target35.59 (8.56%)
Short Float %11.1%
Short Ratio6.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)321.09%
Min EPS beat(2)100.56%
Max EPS beat(2)541.62%
EPS beat(4)4
Avg EPS beat(4)229.77%
Min EPS beat(4)92.16%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)128.87%
EPS beat(12)11
Avg EPS beat(12)92.36%
EPS beat(16)13
Avg EPS beat(16)50.37%
Revenue beat(2)0
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.07%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)9
Avg Revenue beat(16)-0.06%
PT rev (1m)7.53%
PT rev (3m)-3.62%
EPS NQ rev (1m)3.7%
EPS NQ rev (3m)-10.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 364.28
Fwd PE 49.16
P/S 2.9
P/FCF N/A
P/OCF N/A
P/B 5.36
P/tB 106.18
EV/EBITDA N/A
EPS(TTM)0.09
EY0.27%
EPS(NY)0.67
Fwd EY2.03%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS11.32
BVpS6.11
TBVpS0.31
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.08%
ROE -15.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.05%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.47%
Cap/Sales 3.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.7
Altman-Z 2.7
F-Score4
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y675.28%
EPS Next 2Y291.65%
EPS Next 3Y189.04%
EPS Next 5YN/A
Revenue 1Y (TTM)19.36%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%23.05%
Revenue Next Year19.64%
Revenue Next 2Y18.59%
Revenue Next 3Y17.67%
Revenue Next 5Y17.49%
EBIT growth 1Y24.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.26%
EBIT Next 3Y88.55%
EBIT Next 5Y63.98%
FCF growth 1Y62.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.6%
OCF growth 3YN/A
OCF growth 5YN/A